The Latin America, Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market would witness market growth of 6.7% CAGR during the forecast period (2021-2027).
The demand for STD testing is predicted to increase as a result of recommendations from various regulatory bodies for annual STD screening for sexually active men and women. STD screening services are now widely covered by health-care plans, which would likely boost the worldwide STD testing market's growth. For example, under the Affordable Care Act in the United States, STD screening treatments are covered without cost-sharing. STD prevention and control techniques have been specified by regulatory bodies like the World Health Organization.
The prevalence of STDs or STIs are gaining a high momentum in the African region, which is leading to various health problems and serious complications. When compared to other regions, Sub-Saharan Africa has the highest annual STD cases. Infections with the herpes simplex virus and the human papillomavirus are becoming more common in Sub-Saharan Africa. While there are more than 20 bacteria that cause STDs, they mostly manifest themselves in four syndromes and can thus be treated syndromically. Many government and major healthcare organizations are working together to improve the state of medical services, especially STD treatment across this region.
The Brazil market dominated the LAMEA Sexually Transmitted Diseases (STD) Testing Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $2.48 billion by 2027. The Argentina market is poised to grow at a CAGR of 7.3% during (2021 - 2027). Additionally, The UAE market would showcase CAGR of 6.4% during (2021 - 2027).
Based on Disease Type, the market is segmented into Chlamydia, Herpes simplex, Gonorrhea, Syphilis, Human papillomavirus (HPV), and Other Disease. Based on the Location of Testing, the market is segmented into Laboratory Testing and Point of care (POC) Testing. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Sexually Transmitted Diseases (STD) Testing Market is Predict to reach $120 Billion by 2027, at a CAGR of 4.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin Molecular LLC, Danaher Corporation, Bio-Rad Laboratories, Inc., and OraSure Technologies, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Disease Type
- Chlamydia
- Herpes simplex
- Gonorrhea
- Syphilis
- Human papillomavirus (HPV)
- Other Disease
By Location of Testing
- Laboratory Testing
- Point of care (POC) Testing
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- BioMérieux S.A.
- Abbott Laboratories
- Becton, Dickinson and Company
- Hologic, Inc.
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- DiaSorin Molecular LLC
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- OraSure Technologies, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Sexually Transmitted Diseases (STD) Testing Market, by Disease Type
1.4.2 LAMEA Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing
1.4.3 LAMEA Sexually Transmitted Diseases (STD) Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Oct – 2021, Dec) Leading Players
Chapter 4. LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type
4.1 LAMEA Chlamydia Market by Country
4.2 LAMEA Herpes simplex virus Market by Country
4.3 LAMEA Gonorrhea Market by Country
4.4 LAMEA Syphilis Market by Country
4.5 LAMEA Human papillomavirus (HPV) Market by Country
4.6 LAMEA Other Disease Market by Country
Chapter 5. LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
5.1 LAMEA Laboratory Testing Market by Country
5.2 LAMEA Point of care (POC) Testing Market by Country
Chapter 6. LAMEA Sexually Transmitted Diseases (STD) Testing Market by Country
6.1 Brazil Sexually Transmitted Diseases (STD) Testing Market
6.1.1 Brazil Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.2 Brazil Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2 Argentina Sexually Transmitted Diseases (STD) Testing Market
6.2.1 Argentina Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.2 Argentina Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3 UAE Sexually Transmitted Diseases (STD) Testing Market
6.3.1 UAE Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.2 UAE Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market
6.4.1 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.2 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.5 South Africa Sexually Transmitted Diseases (STD) Testing Market
6.5.1 South Africa Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.5.2 South Africa Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.6 Nigeria Sexually Transmitted Diseases (STD) Testing Market
6.6.1 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.6.2 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.7 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market
6.7.1 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.7.2 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
Chapter 7. Company Profiles
7.1 BioMérieux S.A.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Research & Development Expenses
7.2 Abbott Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.3 Becton, Dickinson and Company
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Hologic, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approvals and Trials:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Acquisition and Mergers:
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.6 SWOT Analysis
7.6 F. Hoffmann-La Roche Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Product Launches and Product Expansions:
7.7 DiaSorin Molecular LLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Danaher Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Bio-Rad laboratories, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.10. OraSure Technologies, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional & Segmental Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Product Launches and Product Expansions:
7.10.5.2 Acquisition and Mergers:
TABLE 1 LAMEA Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 2 LAMEA Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Sexually Transmitted Diseases (STD) Testing Market
TABLE 4 Product Launches And Product Expansions– Sexually Transmitted Diseases (STD) Testing Market
TABLE 5 Acquisition and Mergers– Sexually Transmitted Diseases (STD) Testing Market
TABLE 6 approvals and trials– Sexually Transmitted Diseases (STD) Testing Market
TABLE 7 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 8 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 9 LAMEA Chlamydia Market by Country, 2017 - 2020, USD Million
TABLE 10 LAMEA Chlamydia Market by Country, 2021 - 2027, USD Million
TABLE 11 LAMEA Herpes simplex virus Market by Country, 2017 - 2020, USD Million
TABLE 12 LAMEA Herpes simplex virus Market by Country, 2021 - 2027, USD Million
TABLE 13 LAMEA Gonorrhea Market by Country, 2017 - 2020, USD Million
TABLE 14 LAMEA Gonorrhea Market by Country, 2021 - 2027, USD Million
TABLE 15 LAMEA Syphilis Market by Country, 2017 - 2020, USD Million
TABLE 16 LAMEA Syphilis Market by Country, 2021 - 2027, USD Million
TABLE 17 LAMEA Human papillomavirus (HPV) Market by Country, 2017 - 2020, USD Million
TABLE 18 LAMEA Human papillomavirus (HPV) Market by Country, 2021 - 2027, USD Million
TABLE 19 LAMEA Other Disease Market by Country, 2017 - 2020, USD Million
TABLE 20 LAMEA Other Disease Market by Country, 2021 - 2027, USD Million
TABLE 21 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 22 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 23 LAMEA Laboratory Testing Market by Country, 2017 - 2020, USD Million
TABLE 24 LAMEA Laboratory Testing Market by Country, 2021 - 2027, USD Million
TABLE 25 LAMEA Point of care (POC) Testing Market by Country, 2017 - 2020, USD Million
TABLE 26 LAMEA Point of care (POC) Testing Market by Country, 2021 - 2027, USD Million
TABLE 27 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Country, 2017 - 2020, USD Million
TABLE 28 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Country, 2021 - 2027, USD Million
TABLE 29 Brazil Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 30 Brazil Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 31 Brazil Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 32 Brazil Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 33 Brazil Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 34 Brazil Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 35 Argentina Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 36 Argentina Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 37 Argentina Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 38 Argentina Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 39 Argentina Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 40 Argentina Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 41 UAE Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 42 UAE Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 43 UAE Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 44 UAE Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 45 UAE Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 46 UAE Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 47 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 48 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 49 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 50 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 51 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 52 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 53 South Africa Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 54 South Africa Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 55 South Africa Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 56 South Africa Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 57 South Africa Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 58 South Africa Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 59 Nigeria Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 60 Nigeria Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 61 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 62 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 63 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 64 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 65 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 66 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 67 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 68 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 69 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 70 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 71 Key information – BioMérieux S.A.
TABLE 72 Key Information – Abbott Laboratories
TABLE 73 Key information – Becton, Dickinson and Company
TABLE 74 Key information – Hologic, Inc.
TABLE 75 Key Information – Thermo Fisher Scientific, Inc.
TABLE 76 key information – F. Hoffmann-La Roche Ltd.
TABLE 77 Key information – DiaSorin Molecular LLC
TABLE 78 Key Information – Danaher Corporation
TABLE 79 Key Information – Bio-Rad Laboratories, Inc.
TABLE 80 Key information – OraSure Technologies, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 1 KBV Cardinal Matrix
FIG 2 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 3 Key Strategic Move: (Product Launches and Product Expansions : 2019, Oct – 2021, dec) Leading Players
FIG 4 Recent strategies and developments: Hologic, Inc.
FIG 5 Swot analysis: thermo fisher scientific, inc.
FIG 6 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 7 Recent strategies and developments: OraSure Technologies, Inc.